Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type C
暂无分享,去创建一个
W. Pavan | M. Patterson | C. Brewer | A. Gropman | B. Solomon | F. Porter | M. Arcos-Burgos | K. King | N. Yanjanin | S. Bianconi | J. I. Velez | S. K. Conley | S. Conley | Sandra K. Conley
[1] H. Runz,et al. NPC‐db, a Niemann‐Pick type C disease gene variation database , 2008, Human mutation.
[2] J. Repa,et al. Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse , 2007, The Journal of Neuroscience.
[3] M. Patterson,et al. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study , 2007, The Lancet Neurology.
[4] G. Besley,et al. The natural history of Niemann–Pick disease type C in the UK , 2007, Journal of Inherited Metabolic Disease.
[5] B. Klarner,et al. Neuropsychological profile of adult patients with Niemann–Pick C1 (NPC1) mutations , 2007, Journal of Inherited Metabolic Disease.
[6] M. Pineda,et al. Niemann–Pick C disease in Spain: Clinical spectrum and development of a disability scale , 2006, Journal of the Neurological Sciences.
[7] N. Baumann,et al. The adult form of Niemann-Pick disease type C. , 2006, Brain : a journal of neurology.
[8] D. Kipnis,et al. Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann–Pick C disease , 2006, Proceedings of the National Academy of Sciences.
[9] M. Patterson,et al. Therapy of Niemann-Pick disease, type C. , 2004, Biochimica et biophysica acta.
[10] S. Mellon,et al. Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone , 2004, Nature Medicine.
[11] D. Ory. The niemann-pick disease genes; regulators of cellular cholesterol homeostasis. , 2004, Trends in cardiovascular medicine.
[12] E. Nanba,et al. Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity , 2002 .
[13] R. Sokol,et al. Niemann-Pick Disease Type C in Neonatal Cholestasis at a North American Center , 2002, Journal of pediatric gastroenterology and nutrition.
[14] S. Walkley,et al. Critical role for glycosphingolipids in Niemann-Pick disease type C , 2001, Current Biology.
[15] H. Ninomiya,et al. [Niemann-Pick disease type C]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[16] S. Walkley,et al. Neurons in Niemann‐Pick Disease Type C Accumulate Gangliosides as Well as Unesterified Cholesterol and Undergo Dendritic and Axonal Alterations , 2001, Journal of neuropathology and experimental neurology.
[17] R. Wattiaux,et al. Identification of HE1 as the second gene of Niemann-Pick C disease. , 2000, Science.
[18] S. Sherlock,et al. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. , 1993, The Journal of pediatrics.
[19] R. Schiffmann,et al. The effect of cholesterol‐lowering agents on hepatic and plasma cholesterol in Niemann‐Pick disease type C , 1993, Neurology.
[20] S. Sato,et al. A clinical staging classification for type C Niemann‐Pick disease , 1992, Neurology.
[21] R. Brady,et al. Group C Niemann‐Pick disease: faulty regulation of low‐density lipoprotein uptake and cholesterol storage in cultured fibroblasts , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] T. Starzl,et al. Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. , 1986, Pediatrics.
[23] R. Brady,et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[24] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[25] E. Nanba,et al. Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. , 2002, Annals of neurology.